Free Trial

UnitedHealth Group (UNH) Stock Price, News & Analysis

UnitedHealth Group logo
$306.72 -4.60 (-1.48%)
As of 12:41 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About UnitedHealth Group Stock (NYSE:UNH)

Key Stats

Today's Range
$304.79
$313.27
50-Day Range
$273.96
$599.10
52-Week Range
$248.88
$630.73
Volume
7.77 million shs
Average Volume
7.21 million shs
Market Capitalization
$278.24 billion
P/E Ratio
19.77
Dividend Yield
2.88%
Price Target
$426.52
Consensus Rating
Moderate Buy

Company Overview

UnitedHealth Group Incorporated is a multinational, Minnetonka, Minnesota-based healthcare and insurance company. It is the result of 5 decades of mergers and acquisitions that began with the formation of Charter Med Inc in 1974. Charter Med Inc was a privately held medical services firm that was soon rebranded (1978) to United Healthcare Company. United Healthcare Company became the parent and holding company for the Physician’s Health Plan of Minnesota, an early HMO.

The company has had several key phases, including the late 1980s when it entered the pharmacy services industry; the mid-1990s when it made some major acquisitions to consolidate a large portion of the US HMO market, and the “modern” period in which it continues to pursue growth through acquisitions, expansion and deepening penetration. Among the more notable events are the inclusion of John Deere Healthcare and the restructuring of acquired assets into the Optum segment. Optum is UnitedHealth Group Incorporated’s technology-focused division and includes the staffed physical-care facilities located throughout the US.

Today, UnitedHealth Group Incorporated operates as a diversified healthcare company in the United States. It operates in four segments providing healthcare and insurance products globally. The company’s four segments are UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. It is the world’s 7th largest company by revenue and the largest insurer by annual premiums. It is ranked 11th on the Forbes Fortune 500 list and had a market capitalization of nearly $500 billion at the end of 2022. Total revenue in 2022 topped $320 billion.

On a segment basis, The UnitedHealthcare segment is the largest and comprises roughly 80% of the net business. It offers consumer-oriented health benefit plans for businesses and consumers and preventative and well-being services for people over 50. It also manages Medicaid plans, family health plans and dental plans among other services.

The OptumHealth segment is a consumer-oriented platform to access a care providers and services network. The OptumInsight segment provides technology, services and outsourcing to hospitals, physicians and organizations that provide health insurance and/or health plans. The OptumRx segment serves the pharmacy industry including the retail market, home delivery and specialty services. Optum users can connect to physicians, schedule appointments, and even fill their prescriptions.

UnitedHealth Group has a long track record of dividend payments that dates back to 1990. The company also has a track record for increasing its dividend if not on a consistent annual basis. The company does not have a dividend reinvestment plan.

UnitedHealth Group is committed to sustainable operations for its consumers and the planet. To that end, the company has committed to efforts that help control healthcare costs, including telehealth and value-based arrangement with providers. Regarding the environment, the company has committed to net-zero emissions by 2035 which is well ahead of the global target. The company is also committed to health equity or the idea that healthcare opportunities (including employment) be fairly and equitably available to all.

UnitedHealth Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
100th Percentile Overall Score

UNH MarketRank™: 

UnitedHealth Group scored higher than 100% of companies evaluated by MarketBeat, and ranked 1st out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    UnitedHealth Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 16 buy ratings, 8 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    UnitedHealth Group has been the subject of 22 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about UnitedHealth Group's stock forecast and price target.
  • Earnings Growth

    Earnings for UnitedHealth Group are expected to grow by 12.46% in the coming year, from $29.54 to $33.22 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of UnitedHealth Group is 19.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.37.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of UnitedHealth Group is 19.80, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.88.

  • Price to Earnings Growth Ratio

    UnitedHealth Group has a PEG Ratio of 1.37. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    UnitedHealth Group has a P/B Ratio of 2.87. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about UnitedHealth Group's valuation and earnings.
  • Percentage of Shares Shorted

    1.20% of the float of UnitedHealth Group has been sold short.
  • Short Interest Ratio / Days to Cover

    UnitedHealth Group has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in UnitedHealth Group has recently decreased by 2.43%, indicating that investor sentiment is improving.
  • Dividend Yield

    UnitedHealth Group pays a meaningful dividend of 2.64%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    UnitedHealth Group has been increasing its dividend for 15 years.

  • Dividend Coverage

    The dividend payout ratio of UnitedHealth Group is 37.02%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, UnitedHealth Group will have a dividend payout ratio of 26.61% next year. This indicates that UnitedHealth Group will be able to sustain or increase its dividend.

  • Read more about UnitedHealth Group's dividend.
  • Percentage of Shares Shorted

    1.20% of the float of UnitedHealth Group has been sold short.
  • Short Interest Ratio / Days to Cover

    UnitedHealth Group has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in UnitedHealth Group has recently decreased by 2.43%, indicating that investor sentiment is improving.
  • News Sentiment

    UnitedHealth Group has a news sentiment score of 1.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 97 news articles for UnitedHealth Group this week, compared to 66 articles on an average week.
  • Search Interest

    Only 436 people have searched for UNH on MarketBeat in the last 30 days. This is a decrease of -6% compared to the previous 30 days.
  • MarketBeat Follows

    193 people have added UnitedHealth Group to their MarketBeat watchlist in the last 30 days. This is an increase of 91% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, UnitedHealth Group insiders have bought 17,494.57% more of their company's stock than they have sold. Specifically, they have bought $31,607,768.00 in company stock and sold $179,645.00 in company stock.

  • Percentage Held by Insiders

    Only 0.28% of the stock of UnitedHealth Group is held by insiders.

  • Percentage Held by Institutions

    87.86% of the stock of UnitedHealth Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about UnitedHealth Group's insider trading history.
Receive UNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for UnitedHealth Group and its competitors with MarketBeat's FREE daily newsletter.

UNH Stock News Headlines

3 Stocks With Rising Dividends Investors Shouldn’t Ignore
UnitedHealth Group Website and Logo
UnitedHealth Stock Dips: Is This a Value Buy Opportunity?
UnitedHealth Group's recent dividend boost and strategic divestiture efforts, combined with executive stock purchases, highlight its strong investment appeal.
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
RSI stock chart graphic
3 Oversold Stocks Flashing Bullish Reversal Signals (UNH)
Here are three stocks that each have oversold RSIs. However, improving signals and catalysts could suggest we're looking at some great entry points.
See More Headlines

UNH Stock Analysis - Frequently Asked Questions

UnitedHealth Group's stock was trading at $505.86 at the beginning of the year. Since then, UNH stock has decreased by 39.3% and is now trading at $306.96.
View the best growth stocks for 2025 here
.

UnitedHealth Group Incorporated (NYSE:UNH) posted its earnings results on Thursday, April, 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by $0.09. The healthcare conglomerate earned $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a trailing twelve-month return on equity of 26.69% and a net margin of 3.60%.
Read the conference call transcript
.

UnitedHealth Group subsidiaries include these companies: LHC Group, PreferredOne, divvyDOSE, Diplomat Pharmacy, PatientsLikeMe, Equian, Avella Specialty Pharmacy, and more.

UnitedHealth Group's top institutional investors include Vanguard Group Inc. (9.97%), Wellington Management Group LLP (2.85%), Price T Rowe Associates Inc. MD (2.36%) and Northern Trust Corp (1.03%). Insiders that own company stock include Stephen J Hemsley, John F Rex, Andrew Witty, Dirk C Mcmahon, Thomas E Roos, Patrick Hugh Conway, Erin Mcsweeney, John H Noseworthy and Kristen Gil.
View institutional ownership trends
.

Shares of UNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that UnitedHealth Group investors own include BlackRock (BLK), Broadcom (AVGO), ServiceNow (NOW), The Goldman Sachs Group (GS), Illinois Tool Works (ITW), Cuisine Solutions (CUSI) and InnerScope Hearing Technologies (INND).

Company Calendar

Record date for 3/18 Dividend
3/10/2025
Ex-Dividend for 3/18 Dividend
3/10/2025
Dividend Payable
3/18/2025
Last Earnings
4/17/2025
Today
6/16/2025
Record date for 6/24 Dividend
6/16/2025
Ex-Dividend for 6/24 Dividend
6/16/2025
Dividend Payable
6/24/2025
Next Earnings (Estimated)
7/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Hospital & medical service plans
Sub-Industry
Managed Health Care
Current Symbol
NYSE:UNH
Employees
400,000
Year Founded
1977

Price Target and Rating

Average Stock Price Target
$426.52
High Stock Price Target
$700.00
Low Stock Price Target
$270.00
Potential Upside/Downside
+36.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
25 Analysts

Profitability

Trailing P/E Ratio
20.22
Forward P/E Ratio
10.61
P/E Growth
1.37
Net Income
$14.41 billion
Pretax Margin
5.01%

Debt

Sales & Book Value

Annual Sales
$410.06 billion
Cash Flow
$20.19 per share
Price / Cash Flow
15.52
Book Value
$106.78 per share
Price / Book
2.93

Miscellaneous

Free Float
917,247,000
Market Cap
$284.28 billion
Optionable
Optionable
Beta
0.44

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:UNH) was last updated on 6/16/2025 by MarketBeat.com Staff
From Our Partners